The pharmaceutical company Teva has reached a $4.25 billion nationwide settlement, potentially resolving thousands of lawsuits over its role in the U.S. opioid crisis.
The money will go primarily to state and local governments, pending agreement from all involved parties. The dollar amount also includes $1.2 billion worth of generic Narcan, a drug that can reverse an opioid overdose, over the next 10 years, Teva confirmed in a report shared with The Hill.
Teva will also provide $100 million over the next 13 years to Native American tribes.
But the agreement isn’t a concession of Teva’s role in the opioid epidemic.
